U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07462767) titled 'Precision Microbiota Interventions for Senoreduction Trial' on Feb. 22.
Brief Summary: People with HIV who drink alcohol are at increased risk for accelerated aging biology, including increased immune senescence. This randomized, double-blind, crossover clinical trial evaluates two generally recognized as safe (GRAS) microbiota-targeted interventions on immune senescence biomarkers.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
HIV Infections
Alcohol Drinking
Aging
Immunosenescence
Intervention:
DIETARY_SUPPLEMENT: Limosilactobacillus reuteri
Administered as 6 capsules daily (3 twice daily) for 4 weeks. Ea...